T2d Covid19

General Information from the World Health Organization

  • Nature of Disease: COVID-19 is caused by the SARS-CoV-2 coronavirus.

  • Symptoms: Most individuals have mild to moderate respiratory illness, and recovery typically occurs without special treatment.

  • At-Risk Populations: Older individuals and those with pre-existing conditions (e.g., cardiovascular disease, diabetes, chronic respiratory issues, cancer) are at higher risk of serious illness.

  • Prevention:

    • Stay informed about the virus and its transmission.

    • Wash hands frequently or use alcohol-based rubs.

    • Avoid touching the face.

Information from the US Centers for Disease Control and Prevention (CDC)

  • Topics Covered:

    • Infection control

    • Post-exposure prophylaxis (PEP)

    • Symptoms and testing

    • Home care and hospital treatment

    • Links to further resources

Workplace Actions

  • Immediate Steps:

    • Discuss action plans with staff and colleagues.

    • Ensure all staff recognize coronavirus symptoms and practice vigilance.

    • Understand infection control principles and set time to apply them.

    • Display informational posters in the clinic/workplace.

    • Advise patients to delay appointments if they show flu-like symptoms or recent international travel to hotspots.

    • Implement preventative measures to reduce virus transmission.

Optometry Board of Australia Communications

  • Relevant Links:

    • Updates and guidelines from the Optometry Board and AHPRA available via their websites.

    • Information on practice implications from Optometry Australia available online.

Vaccine Development

  • Development Timeline: Fastest vaccine production in history (12-18 months from candidate development, trials, to manufacturing).

  • Current Status: Multiple vaccines released in Australia as of February 2021, requiring extensive logistics for distribution.

Viral Conjunctivitis

  • Symptoms Related to COVID-19:

    • Viral conjunctivitis - Eye redness, irritation, foreign body sensation, tearing, chemosis.

  • Viral Presence in Tears:

    • Studies show SARS-CoV-2 viral particles can be present in ocular secretions.

  • Impact on Contact Lens Wearers:

    • Specific guidance from the optometry community about contact lens usage during the pandemic.

Summary of Advice for Optometry Practice

  • Review fact sheets produced by Optometry Australia regarding infection control practices pertaining to COVID-19.

  • Regularly update staff and adapt practices as necessary based on evolving guidelines.

robot